Leyland_EMph3_Dysp_appendix_revision_1July2019 – Supplemental material for Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain

Leyland, Nicholas, Taylor, Hugh S., Archer, David F, Peloso, Paul M, Soliman, Ahmed M., Palac, Hannah L, Martinez, Marisol, Abrao, Mauricio S.
2019 · doi:10.25384/sage.9873749.v1 · W6964023134
OA: green CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-25 ⓘ

This supplemental material accompanies a study demonstrating that elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Supplemental material, Leyland_EMph3_Dysp_appendix_revision_1July2019 for Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain by Nicholas Leyland, Hugh S Taylor, David F Archer, Paul M Peloso, Ahmed M Soliman, Hannah L Palac, Marisol Martinez and Mauricio S Abrao in Journal of Endometriosis and Pelvic Pain Disorders

My notes (saved in your browser only)

Condition tags

endometriosisdyspareunia

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-11T03:42:44.496353+00:00
License: CC0 · commercial use OK